
No. of Pages: 150 | Report Code: TIPRE00018856 | Category: Life Sciences
No. of Pages: 150 | Report Code: TIPRE00018856 | Category: Life Sciences
1.1 Report Guidance
1.2 Market Segmentation
2.1 Key Insights
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4.1 Market Drivers
4.1.1 Increasing Demand for Tumor Modeling and Biobanking
4.1.2 Surging Adoption of Personalized Drugs
4.2 Market Restraints
4.2.1 Dearth of Skilled Professionals
4.3 Market Opportunities
4.3.1 Focus on Drug Discovery Activities
4.4 Future Trends
4.4.1 Combination of Organoids and Organ-on-a-Chip
4.5 Impact of Drivers and Restraints:
5.1 Europe Organoids Market Revenue (US$ Million), 2021–2031
5.2 Europe Organoids Market Forecast Analysis
6.1 Intestine
6.1.1 Overview
6.1.2 Intestine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.2 Liver
6.2.1 Overview
6.2.2 Liver: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.3 Stomach
6.3.1 Overview
6.3.2 Stomach: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.4 Pancreas
6.4.1 Overview
6.4.2 Pancreas: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.5 Lung
6.5.1 Overview
6.5.2 Lung: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.6 Brain
6.6.1 Overview
6.6.2 Brain: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.7 Kidney
6.7.1 Overview
6.7.2 Kidney: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.1 Developmental Biology Disease
7.1.1 Overview
7.1.2 Developmental Biology Disease: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.2 Pathology of Infectious Disease
7.2.1 Overview
7.2.2 Pathology of Infectious Disease: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.3 Regenerative Medicine
7.3.1 Overview
7.3.2 Regenerative Medicine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.4 Drug Toxicity and Efficacy Testing
7.4.1 Overview
7.4.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.5 Drug Discovery and Personalized Medicine
7.5.1 Overview
7.5.2 Drug Discovery and Personalized Medicine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.1 Pluripotent Stem Cells
8.1.1 Overview
8.1.2 Pluripotent Stem Cells: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.2 Organ-Specific Adult Stem Cell
8.2.1 Overview
8.2.2 Organ-Specific Adult Stem Cell: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.1 Instruments
9.1.1 Overview
9.1.2 Instruments: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.2 Consumables
9.2.1 Overview
9.2.2 Consumables: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.3 Services
9.3.1 Overview
9.3.2 Services: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.1 Micropatterned Plates
10.1.1 Overview
10.1.2 Micropatterned Plates: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2 Ultralow Attachment Plates
10.2.1 Overview
10.2.2 Ultralow Attachment Plates: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3 Hanging Drop
10.3.1 Overview
10.3.2 Hanging Drop: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4 Microdroplet or Emulsion
10.4.1 Overview
10.4.2 Microdroplet or Emulsion: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1 Europe
11.1.1 Europe Organoids Market – Revenue and Forecast Analysis – by Country
11.1.1.1 Europe Organoids Market – Revenue and Forecast Analysis – by Country
11.1.1.2 Germany: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1.1.2.1 Germany: Europe Organoids Market Share – by Type
11.1.1.2.2 Germany: Europe Organoids Market Share – by Application
11.1.1.2.3 Germany: Europe Organoids Market Share – by Source
11.1.1.2.4 Germany: Europe Organoids Market Share – by Offering
11.1.1.2.5 Germany: Europe Organoids Market Share – by Instruments
11.1.1.2.6 Germany: Europe Organoids Market Share – by Consumables
11.1.1.2.7 Germany: Europe Organoids Market Share – by Method
11.1.1.3 France: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1.1.3.1 France: Europe Organoids Market Share – by Type
11.1.1.3.2 France: Europe Organoids Market Share – by Application
11.1.1.3.3 France: Europe Organoids Market Share – by Source
11.1.1.3.4 France: Europe Organoids Market Share – by Offering
11.1.1.3.5 France: Europe Organoids Market Share – by Instruments
11.1.1.3.6 France: Europe Organoids Market Share – by Consumables
11.1.1.3.7 France: Europe Organoids Market Share – by Method
11.1.1.4 United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1.1.4.1 United Kingdom: Europe Organoids Market Share – by Type
11.1.1.4.2 United Kingdom: Europe Organoids Market Share – by Application
11.1.1.4.3 United Kingdom: Europe Organoids Market Share – by Source
11.1.1.4.4 United Kingdom: Europe Organoids Market Share – by Offering
11.1.1.4.5 United Kingdom: Europe Organoids Market Share – by Instruments
11.1.1.4.6 United Kingdom: Europe Organoids Market Share – by Consumables
11.1.1.4.7 United Kingdom: Europe Organoids Market Share – by Method
11.1.1.5 Italy: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1.1.5.1 Italy: Europe Organoids Market Share – by Type
11.1.1.5.2 Italy: Europe Organoids Market Share – by Application
11.1.1.5.3 Italy: Europe Organoids Market Share – by Source
11.1.1.5.4 Italy: Europe Organoids Market Share – by Offering
11.1.1.5.5 Italy: Europe Organoids Market Share – by Instruments
11.1.1.5.6 Italy: Europe Organoids Market Share – by Consumables
11.1.1.5.7 Italy: Europe Organoids Market Share – by Method
11.1.1.6 Spain: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1.1.6.1 Spain: Europe Organoids Market Share – by Type
11.1.1.6.2 Spain: Europe Organoids Market Share – by Application
11.1.1.6.3 Spain: Europe Organoids Market Share – by Source
11.1.1.6.4 Spain: Europe Organoids Market Share – by Offering
11.1.1.6.5 Spain: Europe Organoids Market Share – by Instruments
11.1.1.6.6 Spain: Europe Organoids Market Share – by Consumables
11.1.1.6.7 Spain: Europe Organoids Market Share – by Method
11.1.1.7 Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.1.1.7.1 Rest of Europe: Europe Organoids Market Share – by Type
11.1.1.7.2 Rest of Europe: Europe Organoids Market Share – by Application
11.1.1.7.3 Rest of Europe: Europe Organoids Market Share – by Source
11.1.1.7.4 Rest of Europe: Europe Organoids Market Share – by Offering
11.1.1.7.5 Rest of Europe: Europe Organoids Market Share – by Instruments
11.1.1.7.6 Rest of Europe: Europe Organoids Market Share – by Consumables
11.1.1.7.7 Rest of Europe: Europe Organoids Market Share – by Method
12.1 Overview
12.2 Growth Strategies in Organoids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13.1 STEMCELL Technologies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Molecular Devices, LLC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Hubrecht Organoid Technology
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Definigen
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Organoid Therapeutics
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Corning Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Merck KGaA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 InSphero
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ACRO Biosystems.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Bio-Techne Corp
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 SUN bioscience SA
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 ORGANOID SCIENCES Co., Ltd.
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Crown Bioscience Inc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Sartorius AG
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 3D Biotek LLC
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 Prellis Biologics Inc.
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 3Dnamics Inc.
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
13.19 Cellesce Ltd
13.19.1 Key Facts
13.19.2 Business Description
13.19.3 Products and Services
13.19.4 Financial Overview
13.19.5 SWOT Analysis
13.19.6 Key Developments
14.1 About The Insight Partners
Table 1. Europe Organoids Market Segmentation
Table 2. Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Table 3. Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Type
Table 4. Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application
Table 5. Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Source
Table 6. Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Offering
Table 7. Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Method
Table 8. Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country
Table 9. Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type
Table 10. Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application
Table 11. Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source
Table 12. Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering
Table 13. Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments
Table 14. Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables
Table 15. Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method
Table 16. France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type
Table 17. France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application
Table 18. France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source
Table 19. France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering
Table 20. France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments
Table 21. France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables
Table 22. France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method
Table 23. United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type
Table 24. United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application
Table 25. United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source
Table 26. United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering
Table 27. United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments
Table 28. United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables
Table 29. United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method
Table 30. Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type
Table 31. Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application
Table 32. Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source
Table 33. Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering
Table 34. Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments
Table 35. Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables
Table 36. Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method
Table 37. Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type
Table 38. Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application
Table 39. Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source
Table 40. Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering
Table 41. Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments
Table 42. Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables
Table 43. Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method
Table 44. Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type
Table 45. Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application
Table 46. Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source
Table 47. Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering
Table 48. Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments
Table 49. Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables
Table 50. Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method
Table 51. Recent Organic Growth Strategies in Organoids Market
Table 52. Recent Inorganic Growth Strategies in the Organoids Market
Figure 1. Europe Organoids Market Segmentation – Country
Figure 2. Europe Organoids Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Organoids Market Revenue (US$ Million), 2021–2031
Figure 5. Europe Organoids Market Share (%) – by Type (2023 and 2031)
Figure 6. Intestine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 7. Liver: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 8. Stomach: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 9. Pancreas: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 10. Lung: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 11. Brain: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 12. Kidney: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 13. Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 14. Europe Organoids Market Share (%) – by Application (2023 and 2031)
Figure 15. Developmental Biology Disease: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 16. Pathology of Infectious Disease: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 17. Regenerative Medicine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 18. Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 19. Drug Discovery and Personalized Medicine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 20. Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 21. Europe Organoids Market Share (%) – by Source (2023 and 2031)
Figure 22. Pluripotent Stem Cells: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 23. Organ-Specific Adult Stem Cell: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 24. Europe Organoids Market Share (%) – by Offering (2023 and 2031)
Figure 25. Instruments: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 26. Consumables: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 27. Services: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 28. Europe Organoids Market Share (%) – by Method (2023 and 2031)
Figure 29. Micropatterned Plates: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 30. Ultralow Attachment Plates: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 31. Hanging Drop: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 32. Microdroplet or Emulsion: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 33. Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 34. Europe Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 35. Germany: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 36. France: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 37. United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 38. Italy: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 39. Spain: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 40. Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 41. Growth Strategies in Organoids Market